Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

RVNCRVNC
25 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in REVANCE THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS previously held 0 shares of RVNC (REVANCE THERAPEUTICS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$125,434

Total Shares Change

-7,959

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Decreased
13,662
-44.0%
$41,5320.0%—
0
2024-Q3
Decreased
24,390
-78.8%
$126,5840.0%—
0
2024-Q2
Decreased
115,291
-45.5%
$296,2980.0%—
0
2024-Q1
Increased
211,695
+342.1%
$1M0.0%—
40
2023-Q4
Decreased
47,886
-66.3%
$420,9180.0%—
0
2023-Q3
Decreased
142,302
-35.8%
$1.6M0.0%—
0
2023-Q2
Decreased
221,809
-27.3%
$5.6M0.0%—
0
2023-Q1
Increased
305,181
+37.0%
$9.8M0.0%—
36
2022-Q4
New
222,799
-
$4.1M0.0%—
37
2022-Q3
Exited
0
-100.0%
$00.0%—
0
2022-Q2
Increased
16,721
+129.8%
$231,0840.0%—
37
2022-Q1
Decreased
7,276
-54.4%
$141,8820.0%—
0
2021-Q4
Decreased
15,965
-7.0%
$260,5490.0%—
0
2021-Q3
Increased
17,168
+96.8%
$478.3M0.0%—
50
2021-Q2
Decreased
8,725
-54.0%
$258,6090.0%—
0
2021-Q1
Increased
18,979
+56.0%
$530,4630.0%—
34
2020-Q4
Decreased
12,169
-18.2%
$344,8690.0%—
0
2020-Q3
Increased
14,879
+532.3%
$374,0580.0%—
38
2020-Q2
Decreased
2,353
-85.0%
$57,4600.0%—
0
2020-Q1
Increased
15,695
+198.3%
$232,2860.0%—
37
2019-Q4
Decreased
5,261
-17.2%
$85,3860.0%—
0
2019-Q3
Increased
6,355
+48.9%
$82,6150.0%—
29
2019-Q2
Decreased
4,268
-46.4%
$55,3560.0%—
0
2019-Q1
New
7,959
-
$125,4340.0%—
31

Other major holders of RVNC: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used